About MapMyGenome
MapMyGenome is a company based in Hyderabad (India) founded in 2013 by Subash Lingareddy and Anu Acharya. MapMyGenome has raised $1.69 million across 4 funding rounds from investors including CMS Computers, Currae Healthtech Fund and R Gopala Krishnan. The company has 87 employees as of April 05, 2024. MapMyGenome has completed 1 acquisition, including Microbiome Insights. MapMyGenome offers products and services including Genomepatri, MapmyBiome, Medicamap, and Genomepatri Heritage. MapMyGenome operates in a competitive market with competitors including Bione, Xcode Life, StellarGene, Pregenic and Genessense, among others.
- Headquarter Hyderabad, India
- Employees 87 as on 05 Apr, 2024
- Founders Subash Lingareddy, Anu Acharya
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mapmygenome India Limited
- Date of Incorporation 10 Feb, 2012
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$3.22 M (USD)-76.43as on Mar 31, 2023
-
Net Profit
-$693.37 K (USD)-167.62as on Mar 31, 2023
-
EBITDA
-$520.98 K (USD)-137.61as on Mar 31, 2023
-
Total Equity Funding
$1.69 M (USD)
in 4 rounds
-
Latest Funding Round
$270.72 K (USD), Angel Round
Dec 09, 2019
-
Investors
CMS Computers
& 22 more
-
Employee Count
87
as on Apr 05, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MapMyGenome
MapMyGenome offers a comprehensive portfolio of products and services, including Genomepatri, MapmyBiome, Medicamap, and Genomepatri Heritage.
At-home test for health and wellness genetic insights
Analysis of gut microbiome for digestion and energy
Test for personalized medication responses
Genetic analysis for ancestry and origins
People of MapMyGenome
Unlock access to complete
Unlock access to complete
Funding Insights of MapMyGenome
MapMyGenome has successfully raised a total of $1.69M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $270.72 thousand completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Angel Round — $270,721
-
First Round
First Round
(25 Feb 2015)
- Investors Count 23
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Angel Round - MapMyGenome | Valuation | Arjun Malhotra , M Vidyasagar | |
| Mar, 2018 | Amount | Angel Round - MapMyGenome | Valuation | Ratan N Tata |
|
| Sep, 2017 | Amount | Seed - MapMyGenome | Valuation | Singapore Angel Network |
Investors in MapMyGenome
MapMyGenome has secured backing from 23 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include CMS Computers, Currae Healthtech Fund and R Gopala Krishnan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel network focused on India, Singapore, and U.S based companies
|
Founded Year | Domain | Location | |
|
Venture capital funding and support for healthtech startups.
|
Founded Year | Domain | Location | |
|
IT services and specialized solutions are provided by CMS.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MapMyGenome
MapMyGenome has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Microbiome Insights.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microbiome analysis solutions are provided for academic and industrial researchers.
|
2015 |
Financial Statements - MapMyGenome
Mapmygenome Comparisons
Competitors of MapMyGenome
MapMyGenome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bione, Xcode Life, StellarGene, Pregenic and Genessense, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic kits for microbiome testing are developed to manage health.
|
|
| domain | founded_year | HQ Location |
Provider of personalized health and wellness solutions
|
|
| domain | founded_year | HQ Location |
Provides comprehensive genetic testing solutions for accurate gene analysis and personalized health insights.
|
|
| domain | founded_year | HQ Location |
Provides DNA testing kits and genetic analysis for health predispositions services.
|
|
| domain | founded_year | HQ Location |
Offers a comprehensive genomic wellness screening platform for health insights and personalized solutions.
|
Frequently Asked Questions about MapMyGenome
MapMyGenome was founded in 2013 and raised its 1st funding round 2 years after it was founded.
MapMyGenome is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Anu Acharya is the current CEO of MapMyGenome. They have also founded this company.
MapMyGenome is a funded company, having raised a total of $1.69M across 4 funding rounds to date. The company's 1st funding round was a Seed of $116.41K, raised on Feb 25, 2015.
As of Apr 05, 2024, the latest employee count at MapMyGenome is 87.
Annual revenue of MapMyGenome is $3.22M as on Mar 31, 2023.
MapMyGenome was established in 2013 in Hyderabad, India, by the founders of Ocimum BioSolutions as a privately held entity in the personal genomics and biotechnology sector. Genetic testing is offered to customers, with data organized and analyzed for insights. Counseling is provided to interpret results. Operations include user registration, sample collection, laboratory processing, data analysis, report generation, and genetic counseling sessions.
MapMyGenome's top competitors include Bione, Xcode Life and StellarGene.
MapMyGenome offers Genomepatri, MapmyBiome, Medicamap, and Genomepatri Heritage.
MapMyGenome has made 1 acquisition, including Microbiome Insights.
MapMyGenome has 23 investors. Key investors include CMS Computers, Currae Healthtech Fund, R Gopala Krishnan, Arjun Malhotra, and M Vidyasagar.
The valuation of MapMyGenome is $8.91M as of Dec 2019.